OTCs Could Save Billions In Respiratory Infection Treatment Costs – Study
This article was originally published in The Tan Sheet
Executive Summary
OTC drug therapy during the early stages of upper respiratory infections (URIs) could save up to $4.75 bil. annually in the U.S., according to an analysis conducted by Martin Lipsky, MD, Northwestern University, Feinberg School of Medicine, et al